With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health complications and even hospitalization. Vaccine demand declined an average of more than 60 percent across adult vaccines during the height of pandemic.
One of those adult vaccines is Shingrix for the prevention of shingles.
Joining me today to talk about shingles and the Shingrix vaccine is Dr. Leonard Friedland. Dr. Friedland is Vice President, Director Scientific Affairs and Public Health at GSK Vaccines and a physician.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Stitcher | RSS
Related:
Chickenpox 101 with Donald Kaye, MD
Vaccines: An interview with Dr. Paul Offit
Hepatitis A and the Hep A vaccine
Bacterial meningitis and vaccinations: A discussion with Dr. Leonard Friedland
Flu season is here: Time to get your flu shot
COVID-19 vaccines in Florida: How hospitals manage administering to 65+ population
Kedrab: 1st pediatric trial for Human Rabies Immune Globulin
Japanese encephalitis and the new vaccine recommendations
The growing anti-vaccine movement: A discussion with Dr Peter Hotez
I had the Shingles one year ago and I still am plagued some what with the virus. I am 78 years old, should I still get the covid vaccine shot? And would I be advised to get my First Shingles shot also?